Bjørn Dalhus

Oslo University Hospital — Norway

Chemistry · Physical Sciences

39h-index4.7kcitations173works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Crystallography and molecular interactions(44), Crystallization and Solubility Studies(44), X-ray Diffraction in Crystallography(44), DNA Repair Mechanisms(15), Enzyme Production and Characterization(12)

Publications173 total

Structure-function studies on the serine protease domain of Factor VII activating protease (FSAP)
bioRxiv (Cold Spring Harbor Laboratory)·2025
Identification of a small SN derivative that inhibits CaMKII activity
European Heart Journal·2025
Peptide array-derived optimized secretoneurin variants enhance CaMKII inhibition and reduce pathological cardiomyocyte Ca2+ handling
European Heart Journal·2025
Identification of a Small Secretoneurin Derivative That Inhibits <scp>CaMKIIδ</scp> Activity
Journal of Cellular and Molecular Medicine·2025Open Access
Figure S5 from Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
2025Open Access
Table S4 from Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
2025Open Access
Figure S3 from Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
2025Open Access
Figure S2 from Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
2025Open Access
Figure S4 from Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
2025Open Access
Table S1 from Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
2025Open Access
Table S3 from Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
2025Open Access
Data from Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
2025Open Access
Figure S1 from Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
2025Open Access
Table S2 from Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
2025Open Access
An Alkaliphilic Chitinase Unveils Environment-Dependent Variation in the Canonical Catalytic Machinery of Family-18 Glycoside Hydrolases
Biochemistry·2025· 1 citedOpen Access
Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
Molecular Cancer Therapeutics·2025· 1 citedOpen Access
Engineering of anticancer human immunoglobulin A equipped with albumin for enhanced plasma half-life
PNAS Nexus·2025· 3 citedOpen Access
Structure-function analysis of Factor Seven Activating Protease (FSAP) by in-silico methods and its expression in insect cells.
2025
A homozygous <i>POLR1A</i> variant causes leukodystrophy and affects protein homeostasis
Brain·2023· 5 citedOpen Access
Affinity maturation of TCR-like antibodies using phage display guided by structural modeling
Protein Engineering Design and Selection·2022· 2 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Magnar Bjørås(19), Vincent G. H. Eijsink(10), Carl Henrik Görbitz(9), Jan Terje Andersen(8), Inger Sandlie(8), Ingrun Alseth(8), Malin Bern(6), Paul Hoff Backe(5), Gustav Vaaje‐Kolstad(5), Algirdas Grevys(5), Kine Marita Knudsen Sand(5), Jason Cameron(4), Erik Sebastian Vik(4), Ina Høydal Helle(4), Jeannette Nilsen(4), Kristin Støen Gunnarsen(3), Darrell Sleep(3), William E. Louch(3), Jon K. Laerdahl(3), Zarah Forsberg(3)